116 related articles for article (PubMed ID: 32310180)
1. Diabetes-Induced H3K9 Hyperacetylation Promotes Development of Alzheimer's Disease Through CDK5.
Cai HB; Fan ZZ; Tian T; Li ZC; Zhao CC; Guo WT; Ge ZM
J Alzheimers Dis; 2020; 77(1):75-84. PubMed ID: 32310180
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Control of CDK5 Promoter Regulates Diabetes-Associated Development of Alzheimer's Disease.
Cai HB; Fan ZZ; Tian T; Zhao CC; Ge ZM
J Alzheimers Dis; 2019; 69(3):743-750. PubMed ID: 31156174
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
Miao Y; Guo D; Li W; Zhong Y
J Alzheimers Dis; 2019; 69(1):289-296. PubMed ID: 30958383
[TBL] [Abstract][Full Text] [Related]
4. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modulation of Cdk5 contributes to memory deficiency induced by amyloid fibrils.
Li L; Zhang C; Zi X; Tu Q; Guo K
Exp Brain Res; 2015 Jan; 233(1):165-73. PubMed ID: 25234403
[TBL] [Abstract][Full Text] [Related]
6. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
[TBL] [Abstract][Full Text] [Related]
7. Calpastatin Mediates Development of Alzheimer's Disease in Diabetes.
Zhu L; Gong L; Yang T; Xiao X
J Alzheimers Dis; 2019; 68(3):1051-1059. PubMed ID: 30909245
[TBL] [Abstract][Full Text] [Related]
8. [Effect of electroacupuncture on the P35/P25-cyclin-dependent kinase 5-Tau pathway in hippocampus of rats with Alzheimer's disease].
Wang YY; Gao M; Qiu GP; Xu J; Wu YJ; Xu Y; Wang JR; Sheng HJ; Zhu SJ
Zhen Ci Yan Jiu; 2020 Mar; 45(3):194-201. PubMed ID: 32202710
[TBL] [Abstract][Full Text] [Related]
9. Disruption of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer's disease: Involvement of cyclin-dependent kinase 5-mediated phosphorylation of neuronal nitric oxide synthase at Ser(293).
Kwon KJ; Park JH; Jo I; Song KH; Han JS; Park SH; Han SH; Cho DH
Neurochem Int; 2016 Oct; 99():52-61. PubMed ID: 27296112
[TBL] [Abstract][Full Text] [Related]
10. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.
Xu W; Liu J; Ma D; Yuan G; Lu Y; Yang Y
PLoS One; 2017; 12(2):e0172477. PubMed ID: 28225806
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats.
Zimmer ER; Kalinine E; Haas CB; Torrez VR; Souza DO; Muller AP; Portela LV
Curr Alzheimer Res; 2012 Dec; 9(10):1182-90. PubMed ID: 22515493
[TBL] [Abstract][Full Text] [Related]
12. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
[TBL] [Abstract][Full Text] [Related]
13. Targeted Epigenetic Remodeling of the Cdk5 Gene in Nucleus Accumbens Regulates Cocaine- and Stress-Evoked Behavior.
Heller EA; Hamilton PJ; Burek DD; Lombroso SI; Peña CJ; Neve RL; Nestler EJ
J Neurosci; 2016 Apr; 36(17):4690-7. PubMed ID: 27122028
[TBL] [Abstract][Full Text] [Related]
14. Association between the characteristics of metabolic syndrome and Alzheimer's disease.
Yang HT; Sheen YJ; Kao CD; Chang CA; Hu YC; Lin JL
Metab Brain Dis; 2013 Dec; 28(4):597-604. PubMed ID: 23644927
[TBL] [Abstract][Full Text] [Related]
15. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
[TBL] [Abstract][Full Text] [Related]
16. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE
Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia induces tau hyperphosphorylation.
Lee CW; Shih YH; Wu SY; Yang T; Lin C; Kuo YM
Curr Alzheimer Res; 2013 Mar; 10(3):298-308. PubMed ID: 23036024
[TBL] [Abstract][Full Text] [Related]
18. mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease.
Ma YQ; Wu DK; Liu JK
Mol Med Rep; 2013 Feb; 7(2):623-7. PubMed ID: 23165862
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease.
Song WJ; Son MY; Lee HW; Seo H; Kim JH; Chung SH
PLoS One; 2015; 10(8):e0136950. PubMed ID: 26317805
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of cyclin-dependent kinase 5 is mediated by GCN5.
Lee J; Yun N; Kim C; Song MY; Park KS; Oh YJ
Biochem Biophys Res Commun; 2014 Apr; 447(1):121-7. PubMed ID: 24704205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
